Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3597
Selected: 0
NCT IDTitle
NCT03633591A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone
NCT04540120Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome
NCT06501183Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
NCT04036682A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
NCT02340988Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects
NCT04955262A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab
NCT03455270G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
NCT05917470A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.
NCT01458288A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease
NCT05876780A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency)
NCT02243150Safety, Pharmacokinetic and Pharmacodynamic Study of the CDK 4/6 Inhibitor G1T28-1
NCT07313891A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT
NCT05119790A Study of Mass Balance, Pharmacokinetics, Metabolite Profile, and Metabolite Identification of BIIB122/DNL151 in Healthy Male Subjects
NCT04616430Topical Endoxifen in Women
NCT07259330To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants
NCT06277219A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
NCT03154619Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers
NCT04095481Obalon Navigation/Touch System Post-Approval Study
NCT03364400Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors
NCT00388700A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
NCT07563829NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
NCT05838430Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT04221230Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo
NCT02310906Phase I/II Study of SRP-4053 in DMD Patients
NCT02120547Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment
NCT04004325A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis
NCT05215808SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects
NCT04797715Assessing Clinical Outcomes in Alzheimer's Disease Agitation
NCT03329989Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
NCT01093118A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis
NCT05668949Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT02719574Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
NCT03680521Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma
NCT04240314AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications.
NCT03360747Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)
NCT05417126Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease
NCT06616025This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
NCT05260008Study Assessing Pain Relief After Replacement of the Knee
NCT04076540A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4041 in Healthy Volunteers
NCT02988115Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
NCT05838625Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia
NCT03594058A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)
NCT06246513A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4
NCT03290560Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke
NCT00429923Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)
NCT06433752A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
NCT04130997An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
NCT04734860Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms
NCT01325220Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome
NCT01951274VPD-737 for Treatment of Chronic Pruritus